Products

tBuO-Ste-Glu(OtBu)-AEEA-AEEA-OSU

CAS:1118767-15-9

Quantity:

DMF Num:1118767-15-9

Basic information

CAS NO. 1118767-15-9
Purity ≥98%
English name tBuO-Ste-Glu(OtBu)-AEEA-AEEA-OSU
Molecular formula C47H82N4O15
Molecular weight 943.17
Storage conditions Below -20 ° C

Description

Key Features

Dual tBu Protection:tBuO on Ste and OtBu on Glu enable orthogonal deprotection in Semaglutide synthesis.

AEEA Linker System:Two aminoethoxyethanoic acid (AEEA) units enhance hydrophilicity for improved solubility.

OSU Active Ester:Facilitates efficient coupling with amine-containing peptides, boosting reaction yield by 30%.

 

Applications

Semaglutide Side Chain Modification:

Critical for introducing the C18 fatty acid chain in Semaglutide, enhancing receptor binding and half-life (extended to 7 days in vivo).

Enables site-specific conjugation to the peptide backbone, improving bolic stability by 45%.

Long-Acting Peptide Development:

Used in synthesizing GLP-1 agonists for type 2 diabetes/obesity treatment, reducing dosing frequency.

AEEA linkers optimize pharmacokinetic properties, balancing lipophilicity and water solubility.

Peptide-Drug Conjugate (PDC) Research:

Models for developing fatty acid-conjugated peptides with enhanced cellular uptake.

 

Manufacturing Standards

GMP-Compliant Facility:Produced in ISO 9001:2015 & ISO 14001 certified plant with 100% batch QC.

Global Regulatory Support:Provides DMF, CE, REACH, and US FDA documentation for clinical trials.

Stability Testing:Validated for 24 months at -20°C.

 

Services Offered

Structural Modifications:

Alternative fatty acid chains (C16-C20), isotope labeling (¹³C, ²H) for PK studies.

Custom linker lengths (AEEA x1-x5) to optimize drug release kinetics.

Scalable Production:

100 mg to 10 kg batches, with process validation for GMP-grade materials.

Technical Consultation:

Free synthetic route optimization by our PhD-level peptide chemistry team.

 

Company Profile

15+ Years Experience:Specialized in peptide intermediates for global pharma and biotech industries.

R&D Capability:30+ scientists in a 2,000㎡ state-of-the-art laboratory.

Global FootprintServed 500+ clients in 30+ countries, including top 10 global pharma companies.

 

Contact Us

Email:export@pu-kang.com

Phone:+86-137-0808-4407

Address:Zone 1 and 2, 1-3F, Building 3, Chengdu Cross-Strait Science and Technology Industrial Development Park [Jindi Weixin Wenjiang Intelligent Park], Wenjiang District, Chengdu, China.